Clinical Study Results
How has this study helped participants and researchers?
These results helped researchers learn more about how different types of the MEDI3250
vaccine act and how they affect antibodies in healthy young children.
Researchers look at the results of many studies to decide which vaccines work best and
are safest. This summary shows only the main results from this one study. Other studies
may provide new information or different results.
Further clinical studies with this form of the MEDI3250 vaccine are not planned.
Where can I learn more about this study?
You can find more information about this study on the websites listed below. If a full repor t
of the study results is available, it can also be found here.
• www.clinicaltrials.gov. Once you are on the website, type “NCT03143101” into the
search box and click “Search”.
• www.AstraZenecaClinicalTrials.com. Once you are on the website, type
“D2560C00013” into the search box, and click “Find a Study”.
Full Study Title: A Phase 4 Double-blind Study to Evaluate the Shedding and
Immunogenicity of Trivalent and Quadrivalent Formulations of FluMist in Children
24 to < 48 Months of Age
MedImmune Protocol Number: D2560C00013
MedImmune, LLC, a member of the AstraZeneca Group, sponsored this study and has its
headquarters at One MedImmune Way, Gaithersburg, MD 20837 USA.
The phone number for the AstraZeneca Information Center is +1-877-240-9479.
Thank you!
Clinical study participants belong to a large community of people who take part i n
clinical research around the world. They help researchers answer important health
questions and find medical treatments for participants.
The Center for Information & Study on Clinical Research Participation (CISCRP) is a non-profit organization focused on
educating and informing the public about clinical research participation. CISCRP is not involved
in recruiting patients for clinical studies, nor is it involved in conducting clinical studies.
CISCRP
One Liberty Square, Suite 1100 • Boston, MA 02109
1-877-MED-HERO • www.ciscrp.org
8
Version 2.6 2019_04_10